author-photo

Saewon Chun

University of California, Los Angeles

6

Papers

5

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; Results of a first-in-human Phase I trial.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (5)
NIMG-33. VOLUMETRIC TUMOR MEASUREMENTS ARE SUPERIOR TO 2D BIDIRECTIONAL MEASUREMENTS IN THE EVALUATION OF IDH INHIBITION IN DIFFUSE GLIOMAS: EVIDENCE FROM A PROSPECTIVE PHASE I TRIAL OF IVOSIDENIB

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of Ivosidenib.

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
CTNI-14. EVALUATING METABOLIC ALTERATIONS IN PATIENTS WITH EGFR ACTIVATED RECURRENT GLIOBLASTOMA (RGBM) BY INHIBITING EGFR WITH OSIMERTINIB

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
“Aerobic Glycolytic Imaging” of Human Gliomas Using Combined pH-, Oxygen-, and Perfusion-Weighted Magnetic Resonance Imaging

2021 NeuroImage: Clinical
Show All
- Source
- Cite
- Save
Citations (0)